+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Uterine Fibroid Treatment Device Market by Technology, Mode of Treatment - Global Forecast 2025-2030- Product Image
Uterine Fibroid Treatment Device Market by Technology, Mode of Treatment - Global Forecast 2025-2030- Product Image
Sale

Uterine Fibroid Treatment Device Market by Technology, Mode of Treatment - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460250
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Uterine Fibroid Treatment Device Market grew from USD 560.39 million in 2023 to USD 618.32 million in 2024. It is expected to continue growing at a CAGR of 10.43%, reaching USD 1.12 billion by 2030.

The market for Uterine Fibroid Treatment Devices encompasses a range of medical devices used for the non-invasive or minimally invasive treatment of uterine fibroids, benign tumors in the uterus. These devices are necessary due to the high prevalence of fibroids among women of reproductive age, causing symptoms like heavy menstrual bleeding, pelvic pain, and fertility issues. Key applications include hysteroscopic myomectomy, radiofrequency ablation, and magnetic resonance-guided focused ultrasound (MRgFUS), with end-use scopes primarily in hospitals, ambulatory surgical centers, and specialist clinics. The growth of this market is significantly influenced by rising awareness of women's health, advancements in medical technology augmenting the effectiveness and safety of fibroid treatment devices, and a growing preference for minimally invasive procedures that reduce recovery times and hospital stays. Moreover, expanding healthcare infrastructures in emerging economies present untapped potential opportunities for market players. However, limitations such as high costs of treatment, limited expertise in advanced techniques, and concerns over procedure efficacy and safety challenge the market's growth. Regulatory hurdles and varying insurance coverage also add to these challenges. To capitalize on growth opportunities, market players should focus on innovating cost-effective, safe, and easy-to-use devices, and enhancing training for healthcare providers. Furthermore, investment in research to understand the demographic and genetic factors contributing to uterine fibroid prevalence could lead to better-targeted treatments. Collaborations with healthcare providers to boost awareness and education about treatment options can drive acceptance. The market's nature indicates a moderate to high competition level, with significant room for innovation, particularly in technologies that can provide real-time treatment assessments, further improving treatment success rates and patient outcomes. Emphasizing patient-centered care and advancing device portability and accessibility will be vital for sustained business growth.

Understanding Market Dynamics in the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing occurrence of uterine fibroid worldwide
    • Growing penchant for minimally invasive devices
    • Rising utilization of technologically advanced products
  • Market Restraints
    • Shortage of required infrastructure in developing economies
  • Market Opportunities
    • Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
    • Introduction and development of technologically advanced products
  • Market Challenges
    • Reduced awareness of the device among population

Exploring Porter’s Five Forces for the Uterine Fibroid Treatment Device Market

Porter’s Five Forces framework further strengthens the insights of the Uterine Fibroid Treatment Device Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Uterine Fibroid Treatment Device Market

External macro-environmental factors deeply influence the performance of the Uterine Fibroid Treatment Device Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Uterine Fibroid Treatment Device Market, highlighting leading vendors and their innovative profiles. These include Advanced Surgical Concepts, Boston Scientific Corporation, Conmed Corporation, Coopersurgical Inc., Gynesonics, Inc., Hologic, Inc., Insightec Ltd., Karl Storz SE & Co. KG, Medtronic PLC, Merit Medical Systems, Inc., Minerva Surgical, Inc., Olympus Corporation, Pentax Medical, Smith & Nephew PLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Uterine Fibroid Treatment Device Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Ablation Techniques
      • Cryoablation
      • Hydrothermal Ablation
      • Microwave Ablation
      • Ultrasound Ablation
        • High Intensity Focused Ultrasound
        • MRI-Guided Focused Ultrasound
    • Embolization Techniques
    • Laparoscopic Techniques
      • Laparoscopic Myomectomy
      • Myolysis
    • Surgical Techniques
      • Hysterectomy
      • Myomectomy
  • Mode of Treatment
    • Invasive Treatment
    • Minimally Invasive Treatment
    • Non-Invasive Treatment
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing occurrence of uterine fibroid worldwide
5.1.1.2. Growing penchant for minimally invasive devices
5.1.1.3. Rising utilization of technologically advanced products
5.1.2. Restraints
5.1.2.1. Shortage of required infrastructure in developing economies
5.1.3. Opportunities
5.1.3.1. Favorable initiatives by governments and organizations to increase awareness pertinent to uterine fibroid diagnosis
5.1.3.2. Introduction and development of technologically advanced products
5.1.4. Challenges
5.1.4.1. Reduced awareness of the device among population
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Uterine Fibroid Treatment Device Market, by Technology
6.1. Introduction
6.2. Ablation Techniques
6.2.1. Cryoablation
6.2.2. Hydrothermal Ablation
6.2.3. Microwave Ablation
6.2.4. Ultrasound Ablation
6.2.4.1. High Intensity Focused Ultrasound
6.2.4.2. MRI-Guided Focused Ultrasound
6.3. Embolization Techniques
6.4. Laparoscopic Techniques
6.4.1. Laparoscopic Myomectomy
6.4.2. Myolysis
6.5. Surgical Techniques
6.5.1. Hysterectomy
6.5.2. Myomectomy
7. Uterine Fibroid Treatment Device Market, by Mode of Treatment
7.1. Introduction
7.2. Invasive Treatment
7.3. Minimally Invasive Treatment
7.4. Non-Invasive Treatment
8. Americas Uterine Fibroid Treatment Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Uterine Fibroid Treatment Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
FIGURE 2. UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. UTERINE FIBROID TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. UTERINE FIBROID TREATMENT DEVICE MARKET DYNAMICS
TABLE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYDROTHERMAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MRI-GUIDED FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY EMBOLIZATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOLYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MINIMALLY INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY NON-INVASIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 51. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 53. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 54. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 57. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 59. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 83. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 85. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 86. CHINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 89. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 91. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 92. INDIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 101. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 103. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 104. JAPAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 137. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 139. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 140. THAILAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 156. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 158. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 159. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 162. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 164. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 165. EGYPT UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 168. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 170. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 171. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 174. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 176. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 177. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 180. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 182. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 192. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 194. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 195. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 210. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 212. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 213. NORWAY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 214. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 216. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 218. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 219. POLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 222. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 224. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 225. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 244. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 246. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 248. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 249. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 264. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 266. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 267. TURKEY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABLATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ULTRASOUND ABLATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SURGICAL TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MODE OF TREATMENT, 2018-2030 (USD MILLION)
TABLE 280. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Uterine Fibroid Treatment Device Market, which are profiled in this report, include:
  • Advanced Surgical Concepts
  • Boston Scientific Corporation
  • Conmed Corporation
  • Coopersurgical Inc.
  • Gynesonics, Inc.
  • Hologic, Inc.
  • Insightec Ltd.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Pentax Medical
  • Smith & Nephew PLC
  • Stryker Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 618.32 Million
Forecasted Market Value ( USD ) by 2030 $ 1120 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Uterine Fibroid Treatment Devices Market Report and Forecast 2024-2032 - Product Image

Uterine Fibroid Treatment Devices Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Uterine Fibroid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Uterine Fibroid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Uterine Fibroid Embolization Device Global Market Report 2024 - Product Image

Uterine Fibroid Embolization Device Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Uterine Fibroid (UF) Treatment Device Market 2024-2028 - Product Image

Uterine Fibroid (UF) Treatment Device Market 2024-2028

  • Report
  • 157 Pages
  • Global
From
Uterine Fibroids Treatment Global Market Report 2024 - Product Image

Uterine Fibroids Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device market is a subset of the medical devices sector that centers on products intended for the diagnosis, treatment, or management of uterine fibroids. Uterine fibroids, also known as leiomyomas or myomas, are noncancerous growths of the uterus that often appear during childbearing years. Treatment devices vary in function and application, ranging from diagnostic imaging equipment, such as ultrasound, to therapeutic technologies including minimally invasive surgery tools, endometrial ablation devices, and uterine fibroid embolization materials. With a focus on patient safety and outcome, these devices aim to provide alternatives to traditional surgical procedures, like hysterectomy, that have greater risks and longer recovery times. The market is driven by factors such as the prevalence of the condition among women, technological advancements, and the rising preference for minimally invasive procedures. Prominent players in the Uterine Fibroid Treatment Device market consist of companies that specialize in women's health and surgical products. Some of these include Hologic, Inc., which offers a suite of fibroid treatment solutions; AbbVie Inc., known for its medical devices and pharmaceuticals; Boston Scientific Corporation, which develops minimally invasive medical products; and Medtronic, offering a broad range of medical technologies, including those for treating uterine conditions. Other notable companies include Siemens Healthineers, GE Healthcare, and Philips Healthcare, which provide advanced imaging systems for the diagnosis of uterine Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.